Aniracetam
 | |
 | |
| Klinički podaci | |
|---|---|
| Prodajno ime | AMPAMET, Draganon, Sarpul |
| Drugs.com | Monografija |
| Identifikatori | |
| CAS broj | 72432-10-1  |
| ATC kod | N06BX11 (WHO) |
| PubChem | CID 2196 |
| DrugBank | DB04599 |
| ChemSpider | 2111 |
| KEGG | C13355 |
| ChEBI | CHEBI:47943 |
| ChEMBL | CHEMBL36994 |
Aniracetam je organsko jedinjenje, koje sadrži 12 atoma ugljenika i ima molekulsku masu od 219,237 Da.[1][2][3][4]
Osobine
[уреди | уреди извор]| Osobina | Vrednost |
|---|---|
| Broj akceptora vodonika | 3 |
| Broj donora vodonika | 0 |
| Broj rotacionih veza | 2 |
| Particioni koeficijent[5] (ALogP) | 1,3 |
| Rastvorljivost[6] (logS, log(mol/L)) | -2,0 |
| Polarna površina[7] (PSA, Å2) | 46,6 |
Reference
[уреди | уреди извор]- ^ Nakamura K, Kurasawa M. Nakamura, K.; Kurasawa, M. (2001 May 18). . „Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism”. Eur J Pharmacol. 420 (1): 33—43. PMID 11412837. doi:10.1016/s0014-2999(01)01005-6. Проверите вредност парамет(а)ра за датум:
|date=(помоћ) - ^ Lawrence JJ, Brenowitz S, Trussell LO. Lawrence, J. J.; Brenowitz, S.; Trussell, L. O. (2003 Aug). . „The mechanism of action of aniracetam at synaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors: indirect and direct effects on desensitization”. Mol Pharmacol. 64 (2): 269—78. PMID 12869631. doi:10.1124/mol.64.2.269. Проверите вредност парамет(а)ра за датум:
|date=(помоћ) - ^ Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). . „DrugBank 3.0: A comprehensive resource for 'Omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—D1041. PMC 3013709
. PMID 21059682. doi:10.1093/nar/gkq1126.
- ^ Wishart, David S.; Knox, Craig; Guo, An Chi; Cheng, Dean; Shrivastava, Savita; Tzur, Dan; Gautam, Bijaya; Hassanali, Murtaza (2008). . „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—D906. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.
- ^ Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). . „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o.
- ^ Tetko, Igor V.; Tanchuk, Vsevolod Yu.; Kasheva, Tamara N.; Villa, Alessandro E. P. (2001). . „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
- ^ Ertl, Peter; Rohde, Bernhard; Selzer, Paul (2000). . „Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e.
Literatura
[уреди | уреди извор]- Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
- Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.
Spoljašnje veze
[уреди | уреди извор]
 | Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |
